Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra for glycemic control in adults with rheumatoid arthritis and type 2 diabetes
2012-005370-62Phase 4Terminated
- Sponsor
- San Salvatore Hospital of L'Aquila
- Start
- Jan 2013
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of anakinra in rheumatoid arthritis (RA) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by San Salvatore Hospital of L'Aquila. Primary endpoint: Change in glycated hemoglobin. Started Jan 2013; status: terminated.
02
Drugs
anakinra
03
Conditions
rheumatoid arthritis (RA)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2012-005370-62.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005370-62.